Segui
orhan tansel korkmaz
orhan tansel korkmaz
Eskisehir Osmangazi University , School of Medicine, Department of Physiology
Email verificata su bu.edu
Titolo
Citata da
Citata da
Anno
7, 8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis
OT Korkmaz, N Aytan, I Carreras, JK Choi, NW Kowall, BG Jenkins, ...
Neuroscience letters 566, 286-291, 2014
822014
Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF …
OT Korkmaz, N Tunçel, M Tunçel, EM Öncü, V Şahintürk, M Çelik
Journal of molecular neuroscience 41, 278-287, 2010
552010
Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum
N Tunçel, OT Korkmaz, N Tekin, E Şener, F Akyüz, M İnal
Journal of Molecular Neuroscience 46, 51-57, 2012
502012
A simple and sensitive LC–ESI-MS (ion trap) method for the determination of bupropion and its major metabolite, hydroxybupropion in rat plasma and brain microdialysates
D Yeniceli, E Şener, OT Korkmaz, D Doğrukol-Ak, N Tuncel
Talanta 84 (1), 19-26, 2011
402011
Modulation of corpus striatal neurochemistry by astrocytes and vasoactive intestinal peptide (VIP) in parkinsonian rats
İH Yelkenli, E Ulupinar, OT Korkmaz, E Şener, G Kuş, Z Filiz, N Tunçel
Journal of Molecular Neuroscience 59, 280-289, 2016
302016
Vasoactive intestinal peptide decreases β-amyloid accumulation and prevents brain atrophy in the 5xFAD mouse model of Alzheimer’s disease
OT Korkmaz, H Ay, N Aytan, I Carreras, NW Kowall, A Dedeoglu, N Tuncel
Journal of Molecular Neuroscience 68, 389-396, 2019
272019
Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats
OT Korkmaz, H Ay, E Ulupınar, N Tunçel
Journal of Molecular Neuroscience 48, 565-573, 2012
262012
Advantages of vasoactive intestinal peptide for the future treatment of Parkinson's disease
OT Korkmaz, N Tunçel
Current Pharmaceutical Design 24 (39), 4693-4701, 2018
222018
The effects of vasoactive intestinal peptide on dura mater nitric oxide levels and vessel-contraction responses in sympathectomized rats
F Tore, OT Korkmaz, D Dogrukol-Ak, N Tunçel
Journal of molecular neuroscience 41, 288-293, 2010
132010
Determination of carbamazepine and its main metabolite carbamazepine-10, 11-epoxide in rat brain microdialysate and blood using ESI–LC–MS (ion trap)
E Sener, OT Korkmaz, D Yeniceli, D Dogrukol-Ak, M Tuncel, N Tuncel
Chromatographia 66, 31-36, 2007
132007
Determination of Ochratoxin-A in the brain microdialysates and plasma of awake, freely moving rats using ultra high performance liquid chromatography fluorescence detection method
EMÖ Kaya, OT Korkmaz, DY Uğur, E Şener, AN Tunçel, M Tunçel
Journal of Chromatography B 1125, 121700, 2019
102019
Vasoactive intestinal peptide (VIP) conducts the neuronal activity during absence seizures: GABA seems to be the main mediator of VIP
OT Korkmaz, S Arkan, EM Öncü-Kaya, N Ateş, N Tunçel
Neuroscience Letters 765, 136268, 2021
32021
Can Brain-derived Neurotrophic Factor (BDNF) Mimetics be a Way Out for Neurodegenerative Diseases?
OT Korkmaz
Current Pharmaceutical Design 29 (4), 246-250, 2023
22023
The Effects of Carvacrol on Transient Receptor Potential (TRP) Channels in an Animal Model of Parkinson’s Disease
T Akan, Y Aydın, OT Korkmaz, E Ulupınar, F Saydam
Neurotoxicity Research 41 (6), 660-669, 2023
12023
Determination of carbamazepine and its main metabolite carbamazepine-10, 11-epoxide in rat brain microdialysate and blood using ESI-LC-MS (ion trap)
E Şener, OT Korkmaz, D Yeniceli, D Ak, M Tunçel, N Tuncel
Springer Heidelberg, 2007
12007
Vasoactive Intestinal Peptide Differentially Modulates Neurogenesis in Experimental Parkinson's Disease Models
CC Meral, OT Korkmaz, N Tuncel
ACTA PHYSIOLOGICA 240, 62-62, 2023
2023
Neuroprotective Effects of Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activating Polypeptide-38 (PACAP-38) in Amyotrophic Lateral Sclerosis (ALS) Mouse …
IT Yilmaz, OT Korkmaz, G Kus, EMO Kaya, CCM Evis, M Eser, E Ulupinar, ...
ACTA PHYSIOLOGICA 240, 24-24, 2023
2023
Investigation of the Pharmacokinetic Properties and Theoretical Chemical Activities of 7, 8-Dihydroxyflavone and 4'-Dimethylamino-7, 8-Dihydroxyflavone
MF Karakaya, F Gökalp, E Sener, OT Korkmaz
Current Pharmaceutical Analysis 19 (4), 317-323, 2023
2023
The Relationship between Parkinson's Disease and TRP Channels; Possible Therapeutic Effects of Carvacrol.
T Koca, Y Aydın, T Korkmaz, E Ulupınar, F Saydam
Acta Physiologica 237, 2023
2023
Critical Role of Astrocytes on Striatal Neuro-Chemistry in Vip Treated Parkinsonian Rats
N Tuncel, I Yelkenli, E Ulupınar, OT Korkmaz, E Şener, G Kuş
Humana Press Inc, 2013
2013
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20